(1) – British drugmaker Indivior PLC (INDV.L) withdrew its annual monetary forecast on Wednesday, citing uncertainties as a result of coronavirus pandemic.

The corporate mentioned it doesn’t count on to be in a place to supply revised forecast numbers till the length and extent of the market disruptions brought on by the outbreak are identified.

The blow from the pandemic, which has severely dented international monetary markets, comes at a time when Indivior has already been shedding market share for its best-selling opioid habit remedy Suboxone to cheaper alternate options.

The British drugmaker mentioned on Wednesday it had seen a decline in demand for Sublocade and Perseris injections in current weeks, largely on account of sufferers being unable to go to their healthcare suppliers’ workplaces and a ensuing shift to distant prescribing.

Indivior had gross money of about $911 million and internet money of roughly $673 million as of March 31, the corporate mentioned, including that it’ll present an replace on its monetary efficiency and enterprise developments at its first-quarter outcomes announcement on April 30.

(This story corrects paragraph four to “decline in demand for Sublocade and Perseris injections” from “decline in demand for Suboxone and different merchandise”.)

Reporting by Aakash Jagadeesh Babu in Bengaluru; modifying by Uttaresh.V

Our Requirements:The Thomson 1 Belief Ideas.